Medtronic's implantable drug pump approved in US:
This article was originally published in Clinica
Medtronic has received US FDA approval for its IsoMed constant-flow infusion system, an implantable drug pump for the treatment of colorectal liver cancer. The pump is surgically placed under the skin of the abdomen and delivers cancer-fighting medication directly to the liver, assisted by a catheter that runs from the pump to the hepatic artery. The system can also deliver morphine sulphate directly into spinal fluid as a treatment for chronic back pain, said the Minneapolis, Minnesota-based company.
You may also be interested in...
Plaintiff Peter Lurie, former US FDA associate commissioner, expects results of hundreds of clinical trials of approved drugs will become available under ruling against HHS; co-plaintiff sought eteplirsen study data.
US HHS Office of Inspector General clears company program to provide travel expenses and lodging to needy patients located far from designated treatment centers.